scispace - formally typeset
Journal ArticleDOI

Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy

Reads0
Chats0
TLDR
carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections, indicating the importance of their concurrent evaluation, especially during chronic studies.
Abstract
The competitive relationship between d-amphetamine induced stereotypy and locomotor activity indicates the importance of their concurrent evaluation, especially during chronic studies. Repeated injection of 0.5, 1.0, 2.5, 5.0, or 7.5 mg/kg d-amphetamine for 36 successive days, in rats continuously exposed to the experimental chambers, produced a progressive augmentation in stereotypy and/or locomotion (depending on dose) during the 3–4 hr interval following injections (post-injection phase). In contrast, dark phase locomotor activity (8–20 hr after each daily injection) was maximally reduced (30–40% of controls) after the first injection of either 5.0 or 7.5 mg/kg d-amphetamine and gradually declined to this level with repeated injection of 1.0 and 2.5 mg/kg. Carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections. Possible mechanisms underlying these behavioral alterations are discussed.

read more

Citations
More filters
Journal ArticleDOI

The effect of reserpine on concurrent repeated administration of d-amphetamine

TL;DR: The augmentation of the rat stereotypy response with repeated amphetamine doses, put forward as a model of human amphetamine psychosis, was examined during concurrent reserpinization and showed an earlier onset of stereotypy, as occurred in nonreserpinized rats.
Book ChapterDOI

Discovery and Development of an Anti-methamphetamine Monoclonal Antibody for Use in Treating Methamphetamine Abuse

TL;DR: In a Phase 1a clinical trial, the medication proved safe, with a half-life of 18 days, and patients might only need mAb treatment once every 3 weeks to aid in the protection from relapse to METH abuse.
Journal ArticleDOI

Sustained inhibitory transmission but dysfunctional dopamine D2 receptor signaling in dorsal striatal subregions following protracted abstinence from amphetamine

TL;DR: In this article , the authors show that repeated amphetamine exposure followed by abstinence would alter inhibitory neurotransmission in dorsal striatal subregions, and that repeated drug-exposure produces behavioral sensitization to locomotor-stimulatory properties.

in rotational behavior produced by intermittent injections of amphetamine in male and female rats

TL;DR: The results illustrate an intriguing example of neuroplasticity that may have clinical relevance and indicate that a single injection of a low dose of AMPH enhances rotational behavior induced by a second injection of AM PH for up to 12 weeks.
Book ChapterDOI

The role of scheduling in amphetamine hypersensitivity and tolerance

TL;DR: The possibility that the scheduling of AM might be an important determinant as to which of these two responses occurs is investigated, and the first true demonstration of tolerance to AISB and AILA is demonstrated.
References
More filters
Journal Article

Antiamphetamine effects following inhibition of tyrosine hydroxylase

TL;DR: The antiamphetamine effects of α-MT and other tyrosine hydroxylase inhibitors suggest that a critical level of norepinephrine at the receptor is required for amphetamine to exert its customary effects.
Journal ArticleDOI

Role of Catecholamines in the Amphetamine Excitatory Response

A. Randrup, +1 more
- 30 Jul 1966 - 
TL;DR: The advent of α-methyl para-tyrosine3 (α-MPT), which inhibits the in vivo synthesis of 3,4-dihydroxyphenylalanine (DOPA)—the physiological precursor of the catecholamines—offers a new way of investigating this problem.
Related Papers (5)